Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays. | Commun Biol | 2022 | 36550367 | PubTator, text mining | PubMed |
| Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD. | BMC Med Genomics | 2022 | 36522691 | PubTator, text mining | PubMed |
| A novel non-viral PDCD1 site-integrated CAR design: killing 2 birds with 1 stone. | Blood Sci | 2022 | 36518238 | PubTator, text mining | PubMed |
| Defining cellular population dynamics at single-cell resolution during prostate cancer progression. | Elife | 2022 | 36511483 | PubTator, text mining | PubMed |
| Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects. | J Clin Med | 2022 | 36498574 | PubTator, text mining | PubMed |
| Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors. | Cancers (Basel) | 2022 | 36497465 | PubTator, text mining | PubMed |
| Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. | Cancers (Basel) | 2022 | 36497404 | PubTator, text mining | PubMed |
| Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation. | Cells | 2022 | 36497086 | PubTator, text mining | PubMed |
| Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology. | Front Public Health | 2022 | 36466542 | PubTator, text mining | PubMed |
| Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors. | Front Immunol | 2022 | 36451817 | PubTator, text mining | PubMed |
| Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies. | Cancers (Basel) | 2022 | 36428811 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
| Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428603 | PubTator, text mining | PubMed |
| Advances in the Lung Cancer Immunotherapy Approaches. | Vaccines (Basel) | 2022 | 36423060 | PubTator, text mining | PubMed |
| CAR-T cell combination therapy: the next revolution in cancer treatment. | Cancer Cell Int | 2022 | 36419058 | PubTator, text mining | PubMed |
| Advanced nanomaterial for prostate cancer theranostics. | Front Bioeng Biotechnol | 2022 | 36394009 | PubTator, text mining | PubMed |
| Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation. | Cancer Cell Int | 2022 | 36376956 | PubTator, text mining | PubMed |
| Energetics of the Electron Transfer Pathways in the Homodimeric Photosynthetic Reaction Center. | Biochemistry | 2022 | 36322126 | PubTator, text mining | PubMed |
| Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men. | Sci Rep | 2022 | 36316463 | PubTator, text mining | PubMed |
| Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis. | Nat Commun | 2022 | 36310237 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=14